EVO
Evotec SE
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · DE
$1.86
−2.11%Margins
Gross margin
10.3%
EBITDA margin
-11.9%
EBIT margin
-17.9%
Net margin
-27.8%
FCF margin
-23.4%
-30.0%
Return on equity
-12.7%
Return on assets
-11.3%
Return on invested capital
0.45x
Asset turnover
-$138.3M
Cash from operations
$1.52
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026